脑部放疗，上午比下午敏感许多！. T$ ~& E' _+ _5 B1 s: [
. |- P4 E5 m8 y1 \' i
$ u& d$ B, c8 L. f; Z4 o- g# C# e( P
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.: S! `7 q u1 G, B9 P* _
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?; I4 m, `0 N, ?
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
' Z0 L' `3 V) c* s% QSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA./ O7 f' w* u# G! J+ W; w4 s7 z
* W2 {% B! h* ?8 S) ^
Abstract
+ ]: w# K* ^8 ~; r2 N2 l" rBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
P/ e) R% A( k/ T6 N1 {% T* y& z5 O& \9 O3 C% m' w
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.% s8 d; e. @: p3 ~" C8 }
$ b1 |/ |/ P4 j x# xRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
1 B, E; @1 _7 \/ q j4 j4 o E
Q8 V V* Y* ?5 v6 x: [) ~CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
2 X7 h: F* U l3 d! u/ }$ m7 x0 z& X V6 i5 D5 H' m
|
9 R6 ?& x( e% |8 e/ E: h) n) G
显身卡
